chevron_leftBack
As of 13 June 2026, SunBio,Inc. has a market cap of $66.39M USD, ranking #28479 globally and #1518 in South Korea.
It ranks #2579 in the Healthcare sector, and #919 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$66.39MUSD
100.96B KRW
Revenue (TTM)
$1.43MUSD
2.17B KRW
EBITDA (TTM)
$264.7KUSD
403.98M KRW
Net Income (TTM)
$916.73KUSD
1.39B KRW
EBITDA Margin
19%
Profit Margin
64%
PE Ratio
33.2
PS Ratio
46.5
PB Ratio
22.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Founded
1997
Website
sunbio.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.1% | 13% | 53% | 47% | 41% | 16% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
067370
선바이오
ISIN: KR7067370007
Shares Out.:
Shares Outstanding:
12.165M1
Shares Float:
8.034M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
8,230 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About SunBio,Inc.
SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee. Its preclinical stage biopharmaceuticals candidates target brain stroke and chronic anemia. It also manufactures and sells PEG derivatives. The company was founded in 1997 and is headquartered in Gunpo-si, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.15B
14K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.77B
10K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.24B
8K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.96B
7K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.55B
7K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.44B
7K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
1M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
824K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
543K%
|
97.4
|
|
SIX: RO
|
$321.52B
484K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
435K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
414K%
218.9B CHF
|
20.5
|
chevron_leftBack